A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

Waterfowl birds and their predators are especially at risk of contracting H5N1. Massachusetts has not yet reported a human ...

Moderna completed a Phase I/II clinical trial of an investigational influenza vaccine called mRNA-1018, which was tested against H5 and H7 bird flu subtypes. The company said in a Jan. 17 news ...

Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...

Bird flu has decimated poultry flocks and infected cattle herds. The risk to humans is currently low, but that could easily ...

Until last week, all bird flu in dairy herds had been identified as the B3.13 variant, which was believed to have come from ...

Concerns about bird flu are growing among health officials weeks after the first person in the U.S. died from the virus, and ...

Between January 2022 and November 2024, 1,200 bird flu outbreaks were identified across 48 states, according to a Wildlife ...

As more cases of bird flu emerge across the country, public health leaders in New York City are watching warily -- and making ...

According to the Centers for Disease Control and Prevention (CDC), there have been 67 confirmed human cases of H5N1 bird flu ...